Consistently, higher METTL3 expression at protein levels was observed in human NAFLD-HCC tissues compared to adjacent normal tissues (Figure 1C), as well as in mouse NAFLD-HCC tissues as compared to normal mouse liver tissues (Figure S1C). Here, METTL3 is linked to metabolic dysfunction-associated steatotic liver disease.